- Home
- GALT vs RILY Comparison
GALT vs RILY Comparison
Compare GALT & RILY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- RILY
- Stock Information
- Founded
- GALT 2000
- RILY 1973
- Country
- GALT United States
- RILY United States
- Employees
- GALT N/A
- RILY N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- RILY Investment Managers
- Sector
- GALT Health Care
- RILY Finance
- Exchange
- GALT Nasdaq
- RILY Nasdaq
- Market Cap
- GALT 83.5M
- RILY 91.8M
- IPO Year
- GALT N/A
- RILY 2007
- Fundamental
- Price
- GALT $2.80
- RILY $4.63
- Analyst Decision
- GALT Buy
- RILY
- Analyst Count
- GALT 2
- RILY 0
- Target Price
- GALT $6.00
- RILY N/A
- AVG Volume (30 Days)
- GALT 1.5M
- RILY 1.2M
- Earning Date
- GALT 08-12-2025
- RILY 08-14-2025
- Dividend Yield
- GALT N/A
- RILY N/A
- EPS Growth
- GALT N/A
- RILY N/A
- EPS
- GALT N/A
- RILY N/A
- Revenue
- GALT N/A
- RILY $854,383,000.00
- Revenue This Year
- GALT N/A
- RILY N/A
- Revenue Next Year
- GALT N/A
- RILY N/A
- P/E Ratio
- GALT N/A
- RILY N/A
- Revenue Growth
- GALT N/A
- RILY N/A
- 52 Week Low
- GALT $0.73
- RILY $2.67
- 52 Week High
- GALT $3.90
- RILY $20.80
- Technical
- Relative Strength Index (RSI)
- GALT 67.38
- RILY 81.53
- Support Level
- GALT $2.07
- RILY $4.07
- Resistance Level
- GALT $2.36
- RILY $4.68
- Average True Range (ATR)
- GALT 0.24
- RILY 0.31
- MACD
- GALT 0.03
- RILY 0.16
- Stochastic Oscillator
- GALT 81.11
- RILY 92.61
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About RILY B. Riley Financial Inc.
B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.